These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24840632)

  • 1. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
    Struck-Lewicka W; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
    Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ
    J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of urinary nucleosides. V. Identification of urinary pyrimidine nucleosides by liquid chromatography/electrospray mass spectrometry.
    Bond A; Dudley E; Lemière F; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2006; 20(2):137-50. PubMed ID: 16331740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of urinary nucleosides. II. Comparison of mass spectrometric methods for the analysis of urinary nucleosides.
    Dudley E; Lemiere F; Van Dongen W; Langridge JI; El-Sharkawi S; Games DE; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2001; 15(18):1701-7. PubMed ID: 11555869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Lin WD; Tsai Y; Lin CT; Wang HC; Jeng LB; Lee CC; Lin YC; Lai CC; Tsai FJ
    Clin Chim Acta; 2011 Sep; 412(19-20):1861-6. PubMed ID: 21740897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary modified nucleosides as tumor markers.
    Dudley E; Lemiere F; Van Dongen W; Esmans E; El-Sharkawi AM; Games DE; Brenton AG; Newton RP
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):987-9. PubMed ID: 14565327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic approach for determination of urinary nucleosides as potential tumor markers using electromigration techniques.
    Markuszewski MJ; Struck W; Waszczuk-Jankowska M; Kaliszan R
    Electrophoresis; 2010 Jul; 31(14):2300-10. PubMed ID: 20564268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of urinary nucleosides. I. Optimisation of high performance liquid chromatography/electrospray mass spectrometry.
    Dudley E; El-Sharkawi S; Games DE; Newton RP
    Rapid Commun Mass Spectrom; 2000; 14(14):1200-7. PubMed ID: 10918368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection.
    Lee SH; Jung BH; Kim SY; Chung BC
    Rapid Commun Mass Spectrom; 2004; 18(9):973-7. PubMed ID: 15116424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
    Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry based methods for analysis of nucleosides as antiviral drugs and potential tumor biomarkers.
    Agrofoglio LA; Bezy V; Chaimbault P; Delépée R; Rhourri B; Morin P
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1523-7. PubMed ID: 18066819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
    Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers.
    Godoy AT; Eberlin MN; Simionato AVC
    Talanta; 2020 Apr; 210():120640. PubMed ID: 31987192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry.
    Cho SH; Jung BH; Lee SH; Lee WY; Kong G; Chung BC
    Biomed Chromatogr; 2006 Nov; 20(11):1229-36. PubMed ID: 16799933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.
    Li HY; Wang SM; Liu HM; Bu SS; Li J; Han D; Zhang MZ; Wu GY
    J Mass Spectrom; 2009 May; 44(5):641-51. PubMed ID: 19142897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
    Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
    Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.
    Waszczuk-Jankowska M; Markuszewski MJ; Markuszewski M; Kaliszan R
    Bioanalysis; 2012 Jun; 4(10):1185-94. PubMed ID: 22651562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
    An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
    J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.